Current Ratio of Verve Therapeutics, Inc. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Verve Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2022 to 31 Mar 2025.
  • Verve Therapeutics, Inc. Current Ratio for the quarter ending 31 Mar 2025 was 1238%, a 25% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Verve Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q1 2025 1238% -403% -25% 31 Mar 2025
Q4 2024 1470% -70% -4.5% 31 Dec 2024
Q3 2024 1590% +84% +5.6% 30 Sep 2024
Q2 2024 1639% +20% +1.2% 30 Jun 2024
Q1 2024 1641% +69% +4.4% 31 Mar 2024
Q4 2023 1540% -133% -8% 31 Dec 2023
Q3 2023 1506% -191% -11% 30 Sep 2023
Q2 2023 1619% -56% -3.4% 30 Jun 2023
Q1 2023 1572% -726% -32% 31 Mar 2023
Q4 2022 1673% 31 Dec 2022
Q3 2022 1697% 30 Sep 2022
Q2 2022 1675% 30 Jun 2022
Q1 2022 2297% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.